Securities Code: 002340 Securities Abbreviation: Gremay Announcement No.: 2026-028
Gremay Co., Ltd.
Announcement on Accrual of Credit Impairment Loss and Asset Impairment Loss for 2025
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Gremay Co., Ltd. (hereinafter referred to as the "Company") held the twelfth meeting of the seventh Board of Directors on April 20, 2026, and deliberated and passed the "Proposal on Accrual of Credit Impairment Loss and Asset Impairment Loss for 2025". In accordance with the "Enterprise Accounting Standards", "Stock Listing Rules of the Shenzhen Stock Exchange", "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 1 - Business Handling", and the Company's accounting policies, based on the principle of prudence, impairment tests were conducted on the Company's assets. As of December 31, 2025, credit impairment losses and asset impairment losses were accrued for relevant assets within the scope of the consolidated financial statements for the 2025 fiscal year. The specific situation is hereby announced as follows:
I. Overview of the Accrual of Credit Impairment Loss and Asset Impairment Loss
- Reasons for the Accrual of Impairment Losses
In accordance with the "Enterprise Accounting Standards", "Stock Listing Rules of the Shenzhen Stock Exchange", "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 1 - Business Handling", and the Company's accounting policies, in order to more truthfully and accurately reflect the Company's financial position and asset value, the Company conducted a comprehensive review of all types of assets as of December 31, 2025, and accrued corresponding impairment losses for assets with signs of impairment.
- Scope, Amount, and Reporting Period of Assets for Which Impairment Losses Were Accrued
Audited by Zhidao Certified Public Accountants (Special General Partnership), the Company conducted a comprehensive review and impairment test of assets within the scope of the consolidated financial statements as of December 31, 2025, that may have signs of impairment, such as accounts receivable, other receivables, inventory, long-term equity investments, fixed assets, intangible assets, and goodwill. Accordingly, credit impairment losses of RMB -14,411,172.90 and asset impairment losses of RMB 227,098,914.82 were accrued based on the impairment test results.